Seminars in Liver Disease

Papers
(The H4-Index of Seminars in Liver Disease is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Critical Care Management of Acute-on-Chronic Liver Failure: Certainties and Unknowns70
Tight Junction Proteins as Therapeutic Targets to Treat Liver Fibrosis and Hepatocellular Carcinoma35
Hepatic Extracellular Matrix and Its Role in the Regulation of Liver Phenotype31
A Precision Medicine Guided Approach to the Utilization of Biomarkers in MASLD29
Liver Immunology, Immunotherapy, and Liver Cancers: Time for a Rethink?28
Tailored Model of Care for Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease25
Genetic and Epigenetic Basis of Drug-Induced Liver Injury24
Patient-Reported Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease22
HBV Biomarkers and Their Role in Guiding Treatment Decisions21
Genetic Contributions to Biliary Atresia: A Developmental Cholangiopathy20
Emerging Targets for the Treatment of Primary Sclerosing Cholangitis18
Role of YAP1 Signaling in Biliary Development, Repair, and Disease16
Alcohol Plus Additional Risk Factors: Rodent Model of Liver Injury15
Mechanisms of Pharmacoresistance in Hepatocellular Carcinoma: New Drugs but Old Problems15
0.020511865615845